Gilead Beats Wall Street Estimates (GILD)

Gilead Sciences (NASDAQ: GILD) reported Q4 net income of $802.2 million or $0.87 per share, versus net income of $560.0 million or $0.59 per share in the same quarter last year. On a non-GAAP basis, net income came in at $864.4 million or $0.93 per share, compared to $590.3 million or $0.63 per share in the year ago quarter. Consensus estimates were pegged at $0.85 per share.

Total revenues for the quarter were $2.03 billion, up 42% from $1.43 billion in the comparable quarter last year. Analysts projected that the company would report revenue of $1.39 billion. Gilead (GILD) shares have moved over 3% higher in the after hours on this news and are currently trading at $46.31.